Brand commercialization teams often include representatives from a wide range of functions who weigh in at different stages of the product's life cycle to determine the best strategy from preclinical through post-product launch. Since each product has its own set of unique challenges, no two companies follow the same approach, and there is a growing need to understand external market dynamics and learn how to leverage competitive intelligence to ensure the successful launch of a product.
The 3rd
New Product Planning Summit will bring together cross-functional stakeholders from product development teams at biopharma, medical device, and large pharmaceutical companies and discuss key strategies to effectively commercialize a new product. Join our esteemed speaking faculty as they explore the differences in roles and responsibilities of new product planning professionals based on company size and culture, and share valuable insights and best practices to employ at different stages of a product's life cycle.
Event Highlights
- Discover valuable strategies to guide product development from discovery through launch to ensure the successful commercialization of a new drug
- Develop an effective value proposition using clinical endpoints and patient-reported outcomes that can impact communications with payers and help secure formulary placement
- Gain an overview of organizational structure, functional involvement at each phase of product development, and the optimal utilization of expertise to drive alignment of new product and brand planning with unmet patient needs
- Identify the commercial viability of drug candidates and opportunities for indication expansion to help prioritize and redirect funding to projects with a high potential for success
- Bridge communication gaps between premarket commercialization and global marketing teams to effectively inform the product development process
Who Should Attend
This conference is designed for representatives from pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:
- New Product Planning
- Commercial Assessment/Strategy
- Competitive Intelligence
- Market Research
- Decision Support
- Health Economics and Outcomes Research
- Market Access/Pricing
- Reimbursement Strategy
- Research and Development
- Brand Commercialization
- Medical Strategy
- Clinical Research/Development
- Pharmacology/Pharmacokinetics/Pharmacodynamics
- Portfolio Management
- Regulatory Affairs/Compliance
- Medical Affairs
- Product Development
- Intellectual Property/Legal
- Scientific/Medical Communication
- Publication Planning
- Marketing
- Managed Markets/Care Strategy
- Business Development
- Licensing
Speakers
- Dr. Raymond Donninger, Vice President, Head of Insights and Analytics, PRESCIENT HEALTHCARE GROUP
- Vincent Fisher, Director, Commercial Planning - HIV, GILEAD SCIENCES
- John Garcia, Global Commercial Excellence Lead, ALNYLAM PHARMACEUTICALS
- Abizer Harianawala, Ph.D., Senior Director, Product Development and Technical Operations, TARIS BIOMEDICAL
- Paul Harney, President, North America, PRESCIENT HEALTHCARE GROUP
- Sarah Kurz, Chief Commercial Officer, PARTNER THERAPEUTICS
- Bart Lombardi, Founder and Managing Director, CLARION | A LIFE SCIENCES CONSULTANCY
- Katie MacFarlane, Pharm.D., Founder and Managing Partner, SMARTPHARMA LLC
- Scott Megaffin, Chief Executive Officer, TRAGARA PHARMACEUTICALS INC.
- Charles Pak, Vice President, New Product Planning, SYROS PHARMACEUTICALS
- Brad Payne, MBA, Partner, ARTISAN HEALTHCARE CONSULTING
- Elizabeth Presson, Patient Engagement and Digital Strategy Lead, OTICON MEDICAL
- Tony Russell, Senior Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA
- Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS
- Jake Schutz, Vice President, Southwest Lead, PROMIDIAN CONSULTING
- John Sears, Ph.D., MBA, Health Care Quality and Commercial Strategy Director, JOHNSON & JOHNSON
- Jennifer Sherak, Global Head, Oncology New Product Planning, TAKEDA PHARMACEUTICALS
- Katja Wachtendonk, Worldwide Director New Products, NOVARTIS PHARMACEUTICALS
Please fill in your name and email to receive the Summit Agenda of this event.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Hilton Boston Back Bay40 Dalton St.
Boston, MA 02115
With a unique glass building that offers stunning panoramic views of the Boston skyline, Hilton Back Bay hotel is the perfect setting for world-class shopping, dining, business meetings and events. Our hotel offers 15 meeting rooms with over 15,000 sq. ft. of meeting and event space and is across the street from Hynes Convention Center.
To make reservations over the phone, please call 617-236-1100 or 800-HILTONS and request the negotiated rate for ExL's 3rd New Product Planning Summit. To make reservations online
Click HereYou must book your room by November 20, 2018 in order to receive the group rate. Please book your room early, as rooms available at this rate are limited.
